Cornell Pochily Investment Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $269K | Buy |
+3,856
| New | +$269K | 0.09% | 149 |
|
|
2025
Q1 | – | Sell |
-3,856
| Closed | -$253K | – | 166 |
|
|
2024
Q4 | $253K | Hold |
3,856
| – | – | 0.09% | 147 |
|
|
2024
Q3 | $300K | Hold |
3,856
| – | – | 0.1% | 142 |
|
|
2024
Q2 | $301K | Hold |
3,856
| – | – | 0.11% | 135 |
|
|
2024
Q1 | $261K | Hold |
3,856
| – | – | 0.1% | 148 |
|
|
2023
Q4 | $260K | Sell |
3,856
-2,000
| -34% | -$135K | 0.11% | 151 |
|
|
2023
Q3 | $397K | Hold |
5,856
| – | – | 0.17% | 124 |
|
|
2023
Q2 | $419K | Sell |
5,856
-2,927
| -33% | -$209K | 0.17% | 124 |
|
|
2023
Q1 | $610K | Hold |
8,783
| – | – | 0.26% | 102 |
|
|
2022
Q4 | $595K | Hold |
8,783
| – | – | 0.27% | 99 |
|
|
2022
Q3 | $482K | Hold |
8,783
| – | – | 0.21% | 107 |
|
|
2022
Q2 | $580K | Hold |
8,783
| – | – | 0.26% | 104 |
|
|
2022
Q1 | $583K | Buy |
8,783
+2,270
| +35% | +$151K | 0.23% | 106 |
|
|
2021
Q4 | $379K | Hold |
6,513
| – | – | 0.15% | 128 |
|
|
2021
Q3 | $391K | Hold |
6,513
| – | – | 0.17% | 119 |
|
|
2021
Q2 | $390K | Buy |
+6,513
| New | +$390K | 0.17% | 122 |
|
|
2021
Q1 | – | Sell |
-4,481
| Closed | -$224K | – | 148 |
|
|
2020
Q4 | $224K | Hold |
4,481
| – | – | 0.11% | 136 |
|
|
2020
Q3 | $246K | Buy |
+4,481
| New | +$246K | 0.14% | 126 |
|